Skip to main content

Advertisement

Log in

Her choice: Dealing with lactobacilli, vaginitis, and antibiotics

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Vulvovaginal candidiasis is a common problem for women, yet there are many gaps in knowledge about candida’s pathogenesis, immunity, and its reputed association with antibiotic use. Women often self-diagnose and self-manage the problem, yet one of the most common folk remedies used, the probiotic lactobacillus, has no biologically plausible mechanism to explain any beneficial actions and no rigorous evidence to support its effectiveness. This paper explores these issues and summaries potential areas for further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beigi R, Meyn L, Moore D, et al.: Vaginal yeast colonization in non-pregnant women: a longitudinal study. Obstet Gynecol 2004, 104:926–930. This longitudinal cohort study of over 1200 young women contributed to understanding the transient state of vaginal colonization with candida. Although 70% were colonized by candida in at least one visit, only 4% were colonized at all four visits over the 12 months.

    PubMed  Google Scholar 

  2. Sobel JD, Faro S, Force RW, et al.: Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998, 178:203–211.

    Article  PubMed  CAS  Google Scholar 

  3. Foxman B, Barlow R, D’Arcy H, et al.: Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis 2000, 27:230–235.

    Article  PubMed  CAS  Google Scholar 

  4. Karasz A, Anderson M: The vaginitis monologues: women’s experiences of vaginal complaints in a primary care setting. Soc Sci Med 2002, 56:1013–1021.

    Article  Google Scholar 

  5. Chapple A: Vaginal thrush: perceptions and experiences of women of south Asian descent. Health Educ Res 2001, 16:9–19.

    Article  PubMed  CAS  Google Scholar 

  6. Fidel PJ: Immunity in vaginal candidiasis [Skin and soft tissue infections]. Curr Opin Infect Dis 2005, 18:107–111. Fidel’s review of recent experiments turns on its head previous understandings about the role of human immunity in VVC.

    Article  PubMed  Google Scholar 

  7. Glover D, Larsen B: Relationship of fungal vaginitis therapy to prior antibiotic exposure. Infect Dis Obstet Gynecol 2003, 11:157–161.

    Article  PubMed  Google Scholar 

  8. Glover DD, Larsen B: Longitudinal investigation of candida vaginitis in pregnancy: role of superimposed antibiotic use. Obstet Gynecol 1998, 91:115–118.

    Article  PubMed  CAS  Google Scholar 

  9. Pirotta M, Gunn J, Chondros P, et al.: Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomized controlled trial. BMJ 2004, 329:548–550.

    Article  PubMed  Google Scholar 

  10. Bluestein D, Rutledge C, Lumsden L: Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991, 11:319–326.

    PubMed  CAS  Google Scholar 

  11. MacDonald TM, Beardon PH, McGilchrist MM, et al.: The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Q J Med 1993, 86:419–424.

    PubMed  CAS  Google Scholar 

  12. Spinillo A, Capuzzo E, Acciano S, et al.: Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol 1999, 180:14–17.

    Article  PubMed  CAS  Google Scholar 

  13. Wilton L, Kollarova M, Heeley E, Shakir S: Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 2003, 26:589–597.

    Article  PubMed  CAS  Google Scholar 

  14. Spinillo A, Capuzzo E, Nicola S, et al.: The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995, 51:293–297.

    Article  PubMed  CAS  Google Scholar 

  15. de Leon EM, Jacober SJ, Sobel JD, Foxman B: Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002, 2:1.

    Article  PubMed  Google Scholar 

  16. Geiger AM, Foxman B: Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996, 7:182–187.

    Article  PubMed  CAS  Google Scholar 

  17. Young G, Krasner R, Yudkofsky P: Interactions of oral strains of Candida albicans and lactobacilli. J Bacteriol 1956, 72:525–529.

    PubMed  CAS  Google Scholar 

  18. Demirezen S: The Lactobacilli—Candida relationship in cervico-vaginal smears. Cent Eur J Public Health 2002, 10:97–99.

    PubMed  CAS  Google Scholar 

  19. Hawes SE, Hillier SL, Benedetti J, et al.: Hydrogen peroxideproducing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996, 174:1058–1063.

    PubMed  CAS  Google Scholar 

  20. Agnew KJ, Hillier SL: The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis 1995, 22:269–273.

    Article  PubMed  CAS  Google Scholar 

  21. Lipsky MS, Taylor C: The use of over-the-counter antifungal vaginitis preparations by college students. Fam Med 1996, 28:493–495.

    PubMed  CAS  Google Scholar 

  22. Theroux R: Bypassing the middleman: a grounded theory of women’s self-care for vaginal symptoms. Health Care Women Int 2002, 23:417–431. This qualitative study provides a fascinating insight into women’s decision-making processes to self-care of VVC, from making sense of symptoms to choosing a treatment path, including what women often choose to ‘bypass the middleman’.

    Article  PubMed  Google Scholar 

  23. Pirotta M, Gunn J, Chondros P: ‘Not thrush again!’ Women’s experience of post-antibiotic vulvovaginitis. Med J Aust 2003, 179:43–46.

    PubMed  Google Scholar 

  24. Nyirjesy P, Weitz M, Grody T, Lorber B: Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol 1997, 90:50–53.

    Article  PubMed  CAS  Google Scholar 

  25. O’Dowd T, Parker S, Kelly A: Women’s experiences of general practitioner management of their vaginal symptoms. Br J Gen Pract 1996, 46:415–418.

    PubMed  CAS  Google Scholar 

  26. McGroarty J: Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 1993, 6:251–264.

    Article  PubMed  CAS  Google Scholar 

  27. Kopp-Hoolihan L: Prophylactic and therapeutic uses of probiotics: a review. J Am Dietary Assoc 2001, 101:229–241.

    Article  CAS  Google Scholar 

  28. Redondo-Lopez V, Cook RL, Sobel JD: Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990, 12:856–872.

    PubMed  CAS  Google Scholar 

  29. Burton J, Cadieux P, Reid G: Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003, 69:97–101.

    Article  PubMed  CAS  Google Scholar 

  30. Sobel JD, Chaim W: Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996, 34:2497–2499.

    PubMed  CAS  Google Scholar 

  31. Eschenbach DA, Davick PR, Williams BL, et al.: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989, 27:251–256.

    PubMed  CAS  Google Scholar 

  32. Vallor AC, Antonio MA, Hawes SE, Hillier SL: Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001, 184:1431–1436.

    Article  PubMed  CAS  Google Scholar 

  33. Osset J, Bartolome RM, Garcia E, Andreu A: Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001, 183:485–491.

    Article  PubMed  CAS  Google Scholar 

  34. Fidel PL: History and new insights into host defense against vaginal candidiasis. Trends Microbiol 2004, 12:220–227. In this interesting review, Fidel takes the reader on a historic tour through the experiments performed and views on the role of human immunity in pathogenesis of VVC.

    Article  PubMed  CAS  Google Scholar 

  35. Moncla B: High level vancomycin resistance bacteria in lactobacillus containing probiotic food supplements. Abstracts of the Infectious Diseases Society for Obstetrics and Gynecology. Infect Dis Obstet Gynecol 2002, 10:1–52.

    Article  Google Scholar 

  36. Hamilton-Miller J, Shah S, Smith CT: ‘Probiotic’ remedies are not what they seem. BMJ 1996, 312:55–56.

    PubMed  CAS  Google Scholar 

  37. Cadieux P, Burton J, Gardiner G, et al.: Lactobacillus strains and vaginal ecology. JAMA 2002, 287:1940–1942.

    Article  PubMed  Google Scholar 

  38. Hillier S, Wiesenfeld H, Murray P, et al.: A trial of intravaginal Lactobacillus crispatus as an adjunct to metronidazole therapy for treatment of bacterial vaginosis. Abstracts of the Infectious Diseases Society for Obstetrics and Gynecology. Infect Dis Obstet Gynecol 2002, 10:1–52.

    Article  Google Scholar 

  39. Will TE: Lactobacillus overgrowth for treatment of moniliary vulvovaginitis [letter]. Lancet 1979, 2:482.

    Article  PubMed  CAS  Google Scholar 

  40. Gill H, Rutherford K, Cross M: Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001, 21:264–271.

    Article  PubMed  CAS  Google Scholar 

  41. Cross M, Gill H: Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol 2001, 125:112–119.

    Article  PubMed  CAS  Google Scholar 

  42. Reid G, Bruce AW, Fraser N, et al.: Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001, 30:49–52.

    Article  PubMed  CAS  Google Scholar 

  43. Colodner R, Edelstein H, Chazan B, Raz R: Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003, 5:812–813.

    Google Scholar 

  44. Reid G: Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001, 73(Suppl 2):437S-443S.

    PubMed  CAS  Google Scholar 

  45. Hilton E, Isenberg HD, Alperstein P, et al.: Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992, 116:353–357.

    PubMed  CAS  Google Scholar 

  46. Reid G, Tieszer C, Lam D: Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicans to fibers and epithelial cells. J Ind Microbiol 1995, 15:248–253.

    Article  PubMed  CAS  Google Scholar 

  47. Williams A, Yu C, Tashima K, et al.: Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. J Assoc Nurses AIDS Care 2001, 12:51–57.

    Article  PubMed  CAS  Google Scholar 

  48. Shalev E, Battino S, Weiner E, et al.: Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996, 5:593–596.

    Article  PubMed  CAS  Google Scholar 

  49. Hilton E, Rindos P, Isenberg HD: Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 1995, 33:1433.

    PubMed  CAS  Google Scholar 

  50. Friedlander A, Druker MM, Schachter A: Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection. Panminerva Med 1986, 28:51–53.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pirotta, M.V., Garland, S.M. Her choice: Dealing with lactobacilli, vaginitis, and antibiotics. Curr Infect Dis Rep 7, 445–452 (2005). https://doi.org/10.1007/s11908-005-0046-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-005-0046-5

Keywords

Navigation